Patient receives first infusion of Biogen's controversial Alzheimer's drug

A 70-year-old man from Rhode Island on Wednesday was the first to receive an infusion outside of a clinical trial of Biogen's Alzheimer's drug, Aduhelm.

from Health and Science https://ift.tt/3xpLMwl
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH